Expression of TNF-R and TNF-L in patients under study
| Case number . | CD40 . | CD40L (CD154) . | CD27 . | CD70 (CD27L) . | CD30 . | CD30L . | CD95 (Fas) . | CD95L (FasL) . |
|---|---|---|---|---|---|---|---|---|
| 1 | + | + | − | + | − | − | + | + |
| 2 | + | + | − | + | − | − | + | −* |
| 3 | + | + | − | + | + | − | + | + |
| 4 | + | + | − | + | + | − | + | + |
| 5 | + | + | − | + | + | − | + | + |
| 6 | + | + | − | + | + | − | + | −* |
| 7 | + | − | − | + | + | − | + | −* |
| 8 | + | − | − | + | − | + | + | + |
| 9 | + | − | − | + | + | − | + | + |
| 10 | − | − | + | + | + | − | + | −* |
| 11 | + | + | − | + | − | − | + | + |
| 12 | − | + | − | + | + | − | + | + |
| 13 | + | + | − | + | + | − | + | + |
| 14 | + | ND | − | − | − | − | + | −* |
| 15 | + | + | − | + | + | + | + | + |
| 16 | + | + | + | + | + | − | + | + |
| 17 | − | + | − | + | + | − | + | + |
| 18 | + | + | − | + | + | − | + | −* |
| 19 | + | − | − | + | − | − | + | + |
| 20 | + | + | − | + | + | − | + | + |
| 21 | + | + | − | + | − | − | + | −* |
| Normal CD3+ lymphocytes | − | − | + | − | − | − | + | − |
| Normal CD16+ lymphocytes | − | − | − | − | − | − | + | −* |
| Case number . | CD40 . | CD40L (CD154) . | CD27 . | CD70 (CD27L) . | CD30 . | CD30L . | CD95 (Fas) . | CD95L (FasL) . |
|---|---|---|---|---|---|---|---|---|
| 1 | + | + | − | + | − | − | + | + |
| 2 | + | + | − | + | − | − | + | −* |
| 3 | + | + | − | + | + | − | + | + |
| 4 | + | + | − | + | + | − | + | + |
| 5 | + | + | − | + | + | − | + | + |
| 6 | + | + | − | + | + | − | + | −* |
| 7 | + | − | − | + | + | − | + | −* |
| 8 | + | − | − | + | − | + | + | + |
| 9 | + | − | − | + | + | − | + | + |
| 10 | − | − | + | + | + | − | + | −* |
| 11 | + | + | − | + | − | − | + | + |
| 12 | − | + | − | + | + | − | + | + |
| 13 | + | + | − | + | + | − | + | + |
| 14 | + | ND | − | − | − | − | + | −* |
| 15 | + | + | − | + | + | + | + | + |
| 16 | + | + | + | + | + | − | + | + |
| 17 | − | + | − | + | + | − | + | + |
| 18 | + | + | − | + | + | − | + | −* |
| 19 | + | − | − | + | − | − | + | + |
| 20 | + | + | − | + | + | − | + | + |
| 21 | + | + | − | + | − | − | + | −* |
| Normal CD3+ lymphocytes | − | − | + | − | − | − | + | − |
| Normal CD16+ lymphocytes | − | − | − | − | − | − | + | −* |
Positivity was calculated by comparing the mean fluorescence intensity (MFI) of control and sample, as reported in “Patients, materials, and methods.”
Analysis of surface expression only.
ND: not determined.